ArticleVaccine2020
The role of manufacturers in the implementation of global traceability standards in the supply chain to combat vaccine counterfeiting and enhance safety monitoring.
Article in Vaccine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 41 citations in OpenAlex.
- Comprehensive promotion of drug traceability codes in China in 2025: challenges and solutions for tertiary outpatient pharmacists.Frontiers in pharmacology · 2025Article
- Factors influencing individual vaccine preferences for COVID-19 in the Sunyani Municipality, Ghana: An observational study using discrete choice experiment analysis.Health science reports · 2024Article
- Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries.Vaccine: X · 2023Article
- Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review.Globalization and health · 2023Review
- VaccineChain: A checkpoint assisted scalable blockchain based secure vaccine supply chain with selective revocation.Journal of Industrial Information Integration · 2023Article
- Protecting Vaccine Safety: An Improved, Blockchain-Based, Storage-Efficient Scheme.IEEE transactions on cybernetics · 2023Article
- Article
- Vaccine supply chain management: An intelligent system utilizing blockchain, IoT and machine learning.Journal of business research · 2023Article
- Modeling a sustainable vaccine supply chain for a healthcare system.Journal of cleaner production · 2022Article
- Article
- Leveraging lessons learned from the COVID-19 pandemic for HIV.Communications medicine · 2022Review
- Article
- Challenges to COVID-19 vaccine supply chain: Implications for sustainable development goals.International journal of production economics · 2021Article
- Advancing sustainable development goals through immunization: a literature review.Globalization and health · 2021Review
- Article
Corrections and comments
- Commented on by
Authors and funding
8 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The counterfeiting of vaccines is an increasing problem globally with the safety of persons vaccinated, the trust in vaccines generally and the associated reputation of vaccine manufacturers and regulatory agencies at risk. This risk is especially critical with the on-going development of COVID-19 vaccines. The ability to track and trace vaccines through the vaccine supply chain down to persons vaccinated has to be enhanced. In this context of traceability, the global immunization community has recently set the barcoding of the primary packaging of vaccines, specifically vaccine vials and pre-filled syringes, as a top priority. Emerging vaccine manufacturers are already engaged in investigating ways to incorporate barcoding in their labelling and packaging using GS1 international standards. A specific pilot taking place in Indonesia by the national vaccine manufacturer, Bio Farma, shows the innovation of barcoding on primary packaging already underway with a relatively modest level of investment and success at this stage. This article highlights the efforts of industry and governments on the value of traceability and introduction to 2D barcodes. Access to financial resources and support from the international immunization community would accelerate such innovations leading to enhanced security of the vaccine supply chain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.